Published online Jul 14, 2023. doi: 10.3748/wjg.v29.i26.4214
Peer-review started: March 2, 2023
First decision: May 16, 2023
Revised: May 23, 2023
Accepted: June 13, 2023
Article in press: June 13, 2023
Published online: July 14, 2023
Processing time: 129 Days and 18.5 Hours
Deep angiomyxoma (DAM) is a very rare tumor type. Magnetic resonance imaging (MRI) is considered the best imaging modality for diagnosing DAM. Computed tomography (CT) is used mainly to assess the invasion range of DAM. The value of ultrasonography in the diagnosis of DAM is still controversial. Through a literature review, we summarized the current state of ultrasonic examination for DAM and reported for the first time the contrast-enhanced ultrasound (CEUS) features of DAM seen using a biplane transrectal probe.
A 37-year-old woman presented with a sacrococcygeal mass that had gradually increased in size over the previous 6 mo. MRI and CT examinations failed to allow a definite diagnosis to be made. Transperineal core needle biopsy (CNB) guided by transrectal ultrasound and CEUS was suggested after a multidisciplinary discussion. Grayscale ultrasound of the lesion showed a layered appea
Transrectal CEUS can show the layered perfusion characteristics of the contrast agent, guiding subsequent transperineal CNB of the enhanced area within the DAM.
Core Tip: Deep angiomyxoma (DAM) is a very rare tumor. Imaging examinations play an important role in the diagnosis of DAM. Magnetic resonance imaging is considered the best imaging modality for diagnosing DAM. Computed tomography is used mainly to assess the invasion range of DAM. The value of ultrasonography in the diagnosis of DAM is still controversial. We reported for the first time the contrast-enhanced ultrasound (CEUS) features of DAM seen using a biplane transrectal probe. Transrectal CEUS can provide more abundant diagnostic information in terms of the blood perfusion characteristics of DAM, guiding subsequent transperineal puncture of the enhanced area within the tumor.
